Nevertheless, it is tempting to imagine that variations in the level of NO produced by individuals in response to infection (as a consequence of NOS polymorphism for example [52]), may explain at least partially why some but not all infected patients develop life-threatening diseases such as HUS. The gene discussed is NOS2; the disease is hemolytic-uremic syndrome.